In 2025, researchers studied cardiac prophylactic treatment and mortality in young male DMD patients in the CDC's Muscular Dystrophy Surveillance, Tracking, and Research Network , which collects ...

Prophylactic cardiac treatment may prolong survival in Duchenne muscular dystrophy (DMD), but only one-quarter of individuals received such treatment, a recent study found. January 14th 2025 ...

LINKÖPING, Sweden, April 15, 2025--New MRI Study Explores the Relationship Between AMRA Medical’s Muscle Biomarkers and Functional Changes in Individuals With DMD ...

Monitoring Cardiac Fibrosis in Duchenne Muscular Dystrophy —A study from the Netherlands presents a strong case for strain parameters as critical to monitoring the presence of cardiac fibrosis ...

Capricor Therapeutics announced promising 3-year results from its HOPE-2 extension study for deramiocel in treating Duchenne muscular dystrophy, showing significant cardiac and motor function ...

Symptoms of Duchenne Muscular Dystrophy DMD symptoms usually start by age 6. Symptoms may begin as early as infancy, but most boys don't have any symptoms in the first few years of their life.

Cardiac complications in Duchenne muscular dystrophy (DMD) ... (LVD) typically define normal function as an ejection fraction of 50-55%, and cardiac MRI is also used, ...

Decoding Duchenne Muscular Dystrophy: MRI Study Explores the Relationship Between AMRA’s Muscle Biomarkers and Functional Changes in Individuals With DMD Recent AMRA research examines whether ...

AMRA's muscle biomarkers - Research study explore changes in lean muscle volume (LMV), muscle fat fraction (MFF), and muscle fat infiltration (MFI) Recent AMRA research examines whether the use of MRI ...

Decoding Duchenne Muscular Dystrophy: MRI Study Explores the Relationship Between AMRA’s Muscle Biomarkers and Functional Changes in Individuals With DMD 15 Apr 2025. LINKÖPING, Sweden.